We are live on ! Find out more
OAM

Oxford Asset Management Portfolio holdings

AUM $232M
1-Year Est. Return 31%
This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.8B
AUM Growth
-$421M
Cap. Flow
-$543M
Cap. Flow %
-11.33%
Top 10 Hldgs %
11.23%
Holding
2,126
New
460
Increased
575
Reduced
566
Closed
461

Sector Composition

Rank Sector Weight
1 Technology 16.81%
2 Consumer Discretionary 14.52%
3 Healthcare 12.46%
4 Industrials 12.28%
5 Financials 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLO icon
1451
Flowers Foods
FLO
$1.57B
$351K 0.01%
+19,000
New +$384K
LBRT icon
1452
Liberty Energy
LBRT
$3.25B
$351K 0.01%
+16,275
New +$315K
EIGI
1453
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$350K 0.01%
+39,474
New +$375K
AGIO icon
1454
Agios Pharmaceuticals
AGIO
$1.93B
$349K 0.01%
4,549
-8,375
-65% -$674K
STMP
1455
DELISTED
Stamps.com, Inc.
STMP
$345K 0.01%
1,498
+87
+6% +$21.8K
FISI icon
1456
Financial Institutions
FISI
$821M
$343K 0.01%
10,929
MORN icon
1457
Morningstar
MORN
$7.53B
$343K 0.01%
2,730
-12,883
-83% -$1.74M
CATY icon
1458
Cathay General Bancorp
CATY
$4.24B
$342K 0.01%
8,245
-14,285
-63% -$600K
GYRE icon
1459
Gyre Therapeutics
GYRE
$744M
$342K 0.01%
+4,261
New +$338K
QTS
1460
DELISTED
QTS REALTY TRUST, INC.
QTS
$341K 0.01%
8,093
-21,404
-73% -$934K
EDUC icon
1461
Educational Development Corp
EDUC
$11.8M
$339K 0.01%
29,652
-390
-1% -$4.19K
MLR icon
1462
Miller Industries
MLR
$619M
$339K 0.01%
12,638
+3,066
+32% +$82.5K
MGLN
1463
DELISTED
Magellan Health Services, Inc.
MGLN
$339K 0.01%
4,712
-22,123
-82% -$1.78M
SYRE icon
1464
Spyre Therapeutics
SYRE
$9.25B
$338K 0.01%
1,418
-1,955
-58% -$457K
CCRN
1465
DELISTED
Cross Country Healthcare
CCRN
$337K 0.01%
38,760
-98,702
-72% -$1.01M
CNTY icon
1466
Century Casinos
CNTY
$34M
$337K 0.01%
45,499
-53,002
-54% -$424K
AMNB
1467
DELISTED
American National Bankshares Inc
AMNB
$337K 0.01%
8,591
+1,106
+15% +$45K
KPTI icon
1468
Karyopharm Therapeutics
KPTI
$48M
$335K 0.01%
+1,317
New +$364K
ENTA icon
1469
Enanta Pharmaceuticals
ENTA
$400M
$333K 0.01%
3,762
-35,264
-90% -$3.53M
TECH icon
1470
Bio-Techne
TECH
$11.3B
$333K 0.01%
6,532
-19,884
-75% -$881K
RYTM icon
1471
Rhythm Pharmaceuticals
RYTM
$7.96B
$332K 0.01%
11,426
-2,750
-19% -$86.9K
GENC icon
1472
Gencor Industries
GENC
$212M
$331K 0.01%
27,613
-12,208
-31% -$168K
APTS
1473
DELISTED
Preferred Apartment Communities, Inc.
APTS
$331K 0.01%
+19,022
New +$332K
PPBI
1474
DELISTED
Pacific Premier Bancorp
PPBI
$329K 0.01%
+8,940
New +$342K
KBAL
1475
DELISTED
Kimball International
KBAL
$329K 0.01%
19,531

Similar funds

Oxford Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Oxford Asset Management held 2,126 positions worth $4.8B, down 8.1% from $5.22B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Oxford Asset Management withdrew a net $543M in Q3 2018, closing 461 positions and reducing 566 holdings. Its most notable exit was Cavium, Inc., an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Oxford Asset Management opened a new position in CA, Inc. worth $72.4M.

  • Oxford Asset Management's largest Q3 2018 buy was CA, Inc.: 1,645,180 shares worth $72.4M.
  • Oxford Asset Management added most to GTY Technology Holdings, Inc. Common Stock in Q3 2018, an estimated $26.6M increase.
  • Oxford Asset Management's biggest Q3 2018 reduction was NXP Semiconductors, cutting an estimated $85.7M.
  • Oxford Asset Management fully exited Cavium, Inc. in Q3 2018, selling an estimated $166M.
  • Oxford Asset Management's ten largest holdings make up 11% of its $4.8B portfolio in Q3 2018.
  • Oxford Asset Management opened 460 new positions and closed 461 in Q3 2018.
  • Oxford Asset Management's portfolio value fell 8.1% quarter-over-quarter to $4.8B.

Based on Oxford Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.